Quote:What exactly have Ft. Detrick biowarfare researchers been doing in the Ebola hot zone in West Africa all this time?

Independent investigative reporter Jon Rappoport asked this very same question the day before yesterday, but it seems like a good one. He had several other questions, and they are all good ones:

    What exactly have they been doing?

    Exactly what diagnostic tests have they been performing on citizens of Sierra Leone?

    Why do we have reports that the government of Sierra Leone has recently told Tulane researchers to stop this testing?

    Have Tulane researchers and their associates attempted any experimental treatments (e.g., injecting monoclonal antibodies) using citizens of the region? If so, what adverse events have occurred?

    The research program, occurring in Sierra Leone, the Republic of Guinea, and Liberia—said to be the epicenter of the 2014 Ebola outbreak—has the announced purpose, among others, of detecting the future use of fever-viruses as bioweapons.

    Is this purely defensive research? Or as we have seen in the past, is this research being covertly used to develop offensive bioweapons?

Quote:The same day, Navy Times published an article talking about how U.S. biowarfare scientists have been highly interested in Ebola since at least the late 1970s for engineering bioweapons: “mainly because Ebola and its fellow viruses have high mortality rates…and its stable nature in aerosol make it attractive as a potential biological weapon.”

But the article goes on to say that scientists from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have been working on a vaccine since then, a purely defensive measure. Of course, they can’t come out and say they’re working on offensive weapons. The Biological Weapons Convention went into effect in 1975, supposedly putting an end to the government’s biological weapons program.

Quote:Why does the U.S. government own a patent on a novel strain of Ebola that those same Ft. Detrick researchers quietly admitted in a CDC journal article last month may actually be the cause of the current Sierra Leone outbreak, not Ebola Zaire as widely reported?

Quote:This one gets tricky.

There are five types of Ebola virus and the newest strain is named Bundibugyo, or Ebobun for short. The U.S. government actually holds a patent on this strain — US 20120251502 A1, for “Human Ebola Virus Species and Compositions and Methods Thereof” related to the Bundibugyo version of the virus.

Last month, the same Ft. Detrick researchers who have been over in the Ebola hot zone published an article in the CDC’s Emerging Infectious Diseases where they discuss the human testing that has been going on over there and down near the bottom of the article, they quietly admit,“Ebolavirus infections in Sierra Leone might be the result of Bundibugyo virus or an ebolavirus genetic variant and not EBOV.”

The kicker?

The Ebobun version of Ebola, which is apparently been found to be “genetically distinct,” as it differs by more than 30% at the genome level from all other known ebolavirus species, apparently has a much lower death rate than the Zaire version the media keeps talking about.

Not that Ebola in any form isn’t dangerous. It’s deadly, period. But Ebobun had a 36% mortality rate at the initial outbreak in 2007, versus 70-90% on average for Zaire.

Additionally, because it is much more unique, researchers have suggested that if a vaccine or treatment is created for Ebola and the Ebobun strain is not taken into account, the resulting treatment or vaccine obviously might not work on it.

Regardless, all the mainstream media seems interested in driving home on repeat these days is that this outbreak is the Zaire strain which has a 90% mortality rate and no cure. Well…even that isn’t entirely true…

Quote:even that isn’t entirely true…